A concise, up-to-date review of the many new therapies available for the treatment of benign prostatic hypertrophy (BPH). The authors concisely evaluate the latest minimally invasive therapies, as well as time-tested surgical treatments, and review the medical therapies for BPH, namely a-adrenergic antagonists, 5-a reductase inhibitors, and their therapeutic combinations. Additional chapters examine the pathophysiology and natural history of BPH, its epidemiology, and the urodynamic evaluation of lower urinary tract symptoms. A perfect reference source for the practicing urologist seeking sound guidance on the best approach to his patients.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Numerous recent advances in the medications and technologies available to treat benign prostatic hyperplasia (BPH) raise many questions for practicing urologists seeking optimal therapies for their patients. In Management of Benign Prostatic Hypertrophy, a panel of internationally recognized expert clinicians and investigators in urology review the new treatments in the light of established urologic principles and tradition. The authors concisely evaluate the latest minimally invasive therapies, as well as time-tested surgical treatments, and review the medical therapies for BPH, namely a-adrenergic antagonists, 5a-reductase inhibitors, and their therapeutic combinations. Additional chapters examine the pathophysiology and natural history of BPH, its epidemiology, and the urodynamic evaluation of lower urinary tract symptoms, with special attention given to a more current understanding and treatment of postobstructive diuresis, a significant medical complication and frequent source of urologic consultation.
Grounded in the principles and hallmarks of urology, Management of Benign Prostatic Hypertrophy satisfies the needs of practicing urologists seeking a concise up-to-date interpretation and analysis of the many new therapies available for the treatment of BPH.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
Zustand: New. In. Bestandsnummer des Verkäufers ria9781468498066_new
Anzahl: Mehr als 20 verfügbar
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -A concise, up-to-date review of the many new therapies available for the treatment of benign prostatic hypertrophy (BPH). The authors concisely evaluate the latest minimally invasive therapies, as well as time-tested surgical treatments, and review the medical therapies for BPH, namely a-adrenergic antagonists, 5-a reductase inhibitors, and their therapeutic combinations. Additional chapters examine the pathophysiology and natural history of BPH, its epidemiology, and the urodynamic evaluation of lower urinary tract symptoms. A perfect reference source for the practicing urologist seeking sound guidance on the best approach to his patients. 280 pp. Englisch. Bestandsnummer des Verkäufers 9781468498066
Anzahl: 2 verfügbar
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
Zustand: New. Bestandsnummer des Verkäufers 20389488-n
Anzahl: Mehr als 20 verfügbar
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: New. Bestandsnummer des Verkäufers 20389488-n
Anzahl: Mehr als 20 verfügbar
Anbieter: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irland
Zustand: New. Editor(s): McVary, Kevin T. Series: Current Clinical Urology. Num Pages: 279 pages, 56 black & white illustrations, 3 colour illustrations, biography. BIC Classification: MJS. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 15. Weight in Grams: 413. . 2012. Softcover reprint of the original 1st ed. 2004. Paperback. . . . . Bestandsnummer des Verkäufers V9781468498066
Anzahl: 15 verfügbar
Anbieter: Books Puddle, New York, NY, USA
Zustand: New. pp. 280. Bestandsnummer des Verkäufers 26127779818
Anzahl: 4 verfügbar
Anbieter: preigu, Osnabrück, Deutschland
Taschenbuch. Zustand: Neu. Management of Benign Prostatic Hypertrophy | Kevin T. Mcvary | Taschenbuch | x | Englisch | 2012 | Humana Press | EAN 9781468498066 | Verantwortliche Person für die EU: Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu. Bestandsnummer des Verkäufers 105588997
Anzahl: 5 verfügbar
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
Paperback. Zustand: Brand New. reprint edition. 269 pages. 9.00x6.00x0.75 inches. In Stock. Bestandsnummer des Verkäufers x-1468498061
Anzahl: 2 verfügbar
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland
Taschenbuch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -A concise, up-to-date review of the many new therapies available for the treatment of benign prostatic hypertrophy (BPH). The authors concisely evaluate the latest minimally invasive therapies, as well as time-tested surgical treatments, and review the medical therapies for BPH, namely a-adrenergic antagonists, 5-a reductase inhibitors, and their therapeutic combinations. Additional chapters examine the pathophysiology and natural history of BPH, its epidemiology, and the urodynamic evaluation of lower urinary tract symptoms. A perfect reference source for the practicing urologist seeking sound guidance on the best approach to his patients.Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin 280 pp. Englisch. Bestandsnummer des Verkäufers 9781468498066
Anzahl: 1 verfügbar
Anbieter: Buchpark, Trebbin, Deutschland
Zustand: Sehr gut. Zustand: Sehr gut | Seiten: 280 | Sprache: Englisch | Produktart: Bücher | A concise, up-to-date review of the many new therapies available for the treatment of benign prostatic hypertrophy (BPH). The authors concisely evaluate the latest minimally invasive therapies, as well as time-tested surgical treatments, and review the medical therapies for BPH, namely a-adrenergic antagonists, 5-a reductase inhibitors, and their therapeutic combinations. Additional chapters examine the pathophysiology and natural history of BPH, its epidemiology, and the urodynamic evaluation of lower urinary tract symptoms. A perfect reference source for the practicing urologist seeking sound guidance on the best approach to his patients. Bestandsnummer des Verkäufers 24299491/2
Anzahl: 1 verfügbar